Kiniksa Pharmaceuticals To Present At Upcoming Investor Conferences

2026-05-29 04:16:15

(MENAFN- GlobeNewsWire - Nasdaq) LONDON, May 29, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor conferences in June:

2026 Jefferies Global Healthcare Conference on Wednesday, June 3 at 8:45 a.m. Eastern Time
Goldman Sachs 47^th Annual Global Healthcare Conference on Tuesday, June 9 at 11:20 a.m. Eastern Time

A live webcast of Kiniksa's presentations will be accessible through the Investors & Media section of the company's website at . A replay of the events will also be available on Kiniksa's website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa's portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit .

Every Second Counts! ^®

Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
...

MENAFN29052026004107003653ID1111185181

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.